Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (11): 939-949.doi: 10.35541/cjd.20220420
• Guidelines and Consensus • Previous Articles Next Articles
Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care; National Clinical Research Center for Dermatologic and Immunologic Diseases
Received:2022-06-13
Revised:2022-08-03
Online:2022-11-15
Published:2022-11-03
Contact:
Jin Hongzhong; Lu Qianjin
E-mail:jinhongzhong@263.net; qianlu5860@ pumcderm.cams.cn
Supported by:Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis （2022）[J]. Chinese Journal of Dermatology, 2022, 55(11): 939-949.doi:10.35541/cjd.20220420
| ［1］ | Lundberg IE, Fujimoto M, Vencovsky J, et al. Idiopathic inflammatory myopathies［J］. Nat Rev Dis Primers, 2021,7（1）:86. doi: 10.1038/s41572⁃021⁃00321⁃x. |
| ［2］ | Schlecht N, Sunderkötter C, Niehaus S, et al. Update on dermatomyositis in adults［J］. J Dtsch Dermatol Ges, 2020,18（9）:995⁃1013. doi: 10.1111/ddg.14267. |
| ［3］ | DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis［J］. J Am Acad Dermatol, 2020,82（2）:267⁃281. doi: 10.1016/j.jaad.2019.06.1309. |
| ［4］ | Quinter SD, Chiu YE, Lyon VB, et al. Inverse Gottron′s papules: an unusual cutaneous manifestation of juvenile dermatomyositis［J］. Pediatr Dermatol, 2012,29（5）:641⁃644. doi: 10.1111/j.1525⁃1470.2011.01585.x. |
| ［5］ | Cao H, Xia Q, Pan M, et al. Gottron papules and Gottron sign with ulceration: a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis［J］. J Rheumatol, 2016,43（9）:1735⁃1742. doi: 10.3899/jrheum.160024. |
| ［6］ | Xu X, Chen B, Huang J, et al. Seborrheic dermatitis⁃distributed rash in dermatomyositis is associated with progressive interstitial lung disease［J］. J Am Acad Dermatol, 2021,84（6）:1694⁃1696. doi: 10.1016/j.jaad.2020.12.021. |
| ［7］ | Xu X, Huang J, Wang X, et al. Pseudoangioedema in dermatomyositis patients indicates severe disease and poor prognosis［J］. J Am Acad Dermatol, 2022,86（2）:474⁃475. doi: 10.1016/j.jaad.2021.09.043. |
| ［8］ | 中华医学会风湿病学分会. 多发性肌炎和皮肌炎诊断及治疗指南［J］. 中华风湿病学杂志, 2010,14（12）:828⁃831. doi: 10.3760/cma.j.issn.1007⁃7480.2010.12.008. |
| ［9］ | Connors GR, Christopher⁃Stine L, Oddis CV, et al. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?［J］. Chest, 2010,138（6）:1464 ⁃ 1474. doi: 10.1378/chest.10⁃0180. |
| ［10］ | 孙宇新, 张泽煜, 邵池, 等. 抗黑色素瘤分化相关基因5抗体相关性快速进展性间质性肺疾病的诊治进展［J］. 中华结核和呼吸杂志, 2021,44（9）:837⁃839. doi: 10.3760/cma.j.cn112147⁃20201105⁃01083. |
| ［11］ | Danieli MG, Gelardi C, Guerra F, et al. Cardiac involvement in polymyositis and dermatomyositis［J］. Autoimmun Rev, 2016,15（5）:462⁃465. doi: 10.1016/j.autrev.2016.01.015. |
| ［12］ | Ungprasert P, Suksaranjit P, Spanuchart I, et al. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta ⁃ analysis of observational studies［J］. Semin Arthritis Rheum, 2014,44（1）:63⁃67. doi: 10.1016/j.semarthrit.2014.03.004. |
| ［13］ | Ghate J, Katsambas A, Augerinou G, et al. Review article: a therapeutic update on dermatomyositis/polymyositis［J］. Int J Dermatol, 2000,39（2）:81⁃87. doi: 10.1046/j.1365⁃4362.2000. 00851.x. |
| ［14］ | Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study［J］. J Rheumatol, 2015,42（2）:282⁃291. doi: 10.3899/jrheum.140566. |
| ［15］ | Wang J, Guo G, Chen G, et al. Meta⁃analysis of the association of dermatomyositis and polymyositis with cancer［J］. Br J Dermatol, 2013,169（4）:838⁃847. doi: 10.1111/bjd.12564. |
| ［16］ | Ghirardello A, Bassi N, Palma L, et al. Autoantibodies in polymyositis and dermatomyositis［J］. Curr Rheumatol Rep, 2013,15（6）:335. doi: 10.1007/s11926⁃013⁃0335⁃1. |
| ［17］ | Gono T, Kawaguchi Y, Hara M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis［J］. Rheumatology （Oxford）, 2010,49（7）:1354⁃1360. doi: 10.1093/rheumatology/keq073. |
| ［18］ | Kohsaka H, Mimori T, Kanda T, et al. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists［J］. Mod Rheumatol, 2019,29（1）:1⁃19. doi: 10.1080/14397595.2018.152 1185. |
| ［19］ | Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis［J］. Mod Rheumatol, 2018,28（6）:913⁃921. doi: 10.1080/14397595.2018.1467257. |
| ［20］ | Mammen AL, Allenbach Y, Stenzel W, et al. 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14 ⁃ 16 December 2018［J］. Neuromuscul Disord, 2020,30（1）:70 ⁃ 92. doi: 10.1016/j.nmd.2019.10.005. |
| ［21］ | Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment［J］. J Am Acad Dermatol, 2020,82（2）:283⁃296. doi: 10.1016/j.jaad.2019.05.105. |
| ［22］ | Gono T, Kuwana M. Current understanding and recent advances in myositis⁃specific and ⁃associated autoantibodies detected in patients with dermatomyositis［J］. Expert Rev Clin Immunol, 2020,16（1）:79⁃89. doi: 10.1080/1744666X.2019.1699059. |
| ［23］ | Sunderkötter C, Nast A, Worm M, et al. Guidelines on dermatomyositis⁃excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology［J］. J Dtsch Dermatol Ges, 2016,14（3）:321⁃338. doi: 10.1111/ddg. 12909. |
| ［24］ | 王子璇, 宋小慧, 胡赟赟, 等. 特发性炎症性肌病肌肉病变的诊断及活动度评估［J］. 中国皮肤性病学杂志, 2022,36（7）:733⁃738. doi: 10.13735/j.cjdv.1001⁃7089.202110044. |
| ［25］ | 李霞, 丁晓毅, 郑捷. MRI诊断皮肌炎与多发性肌炎的探讨［J］. 诊断学理论与实践, 2004,3（4）:257⁃259. doi: 10.16150/j.1671⁃2870.a1978. |
| ［26］ | Bohan A, Peter JB. Polymyositis and dermatomyositis（first of two parts）［J］. N Engl J Med, 1975,292（7）:344⁃347. doi: 10.1056/NEJM197502132920706. |
| ［27］ | Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups［J］. Arthritis Rheumatol, 2017,69（12）:2271⁃2282. doi: 10.1002/art.40320. |
| ［28］ | Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects［J］. Dermatol Clin, 2002,20（3）:387⁃408. doi: 10.1016/s0733⁃8635（02）00021⁃9. |
| ［29］ | 中国医师协会皮肤科医师分会自身免疫性疾病亚专业委员会. 糖皮质激素治疗免疫相关性皮肤病专家共识（2018年）［J］. 中华临床免疫和变态反应杂志, 2018,12（1）:1⁃7. doi:10.3969/j.issn.1673⁃8705.2018.01.001. |
| ［30］ | Hoff LS, de Souza F, Miossi R, et al. Long⁃term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis ［J］. Rheumatology（Oxford）, 2022,61（4）:1579⁃1588. doi: 10.1093/rheumatology/keab597. |
| ［31］ | Villalba L, Hicks JE, Adams EM, et al. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens［J］. Arthritis Rheum, 1998,41（3）:392 ⁃ 399. doi: 10.1002/1529⁃0131（199803）41:3<392::AID⁃ART3>3.0.CO;2⁃X. |
| ［32］ | 卢紫函, 陈衍安, 郑敏. JAK抑制剂治疗难治性皮肌炎的研究进展［J］. 中国皮肤性病学杂志, 2022,36（5）:599⁃602. doi: 10.13735/j.cjdv.1001⁃7089.202101167. |
| ［33］ | Sato S, Kuwana M. Clinically amyopathic dermatomyositis［J］. Curr Opin Rheumatol, 2010,22（6）:639⁃643. doi: 10.1097/BOR.0b013e32833f1987. |
| ［34］ | Grinnell M, Keyes E, Diaz D, et al. Mycophenolate mofetil and methotrexate efficacy in dermatomyositis［J］. Br J Dermatol, 2022. doi: 10.1111/bjd.21235. |
| ［35］ | Mainetti C, Terziroli Beretta ⁃ Piccoli B, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review［J］. Clin Rev Allergy Immunol, 2017,53（3）:337⁃356. doi: 10. 1007/s12016⁃017⁃8652⁃1. |
| ［36］ | Tang K, Zhang H, Jin H. Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department［J］. Front Med （Lausanne）, 2021,8:783416. doi: 10.3389/fmed.2021.783416. |
| ［37］ | Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis⁃associated interstitial lung disease［J］. N Engl J Med, 2019,381（3）:291⁃293. doi: 10.1056/NEJMc1900045. |
| ［38］ | Munira S, Christopher⁃Stine L. Pregnancy in myositis and scleroderma［J］. Best Pract Res Clin Obstet Gynaecol, 2020,64:59⁃67. doi: 10.1016/j.bpobgyn.2019.10.004. |
| ［39］ | Tang K, Zhou J, Lan Y, et al. Pregnancy in adult⁃onset dermatomyositis/polymyositis: a systematic review［J］. Am J Reprod Immunol, 2022: e13603. doi: 10.1111/aji.13603 |
| ［40］ | Meisterfeld S, Röber N, Conrad K, et al. A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor 1 ⁃ γ［J］. Br J Dermatol, 2017,177（2）:590 ⁃ 593. doi: 10.1111/bjd. 15468. |
| [1] | Lei Jiehao, Hong Weisong, Lin Fuquan, Hu Wenting, Xu Ai′e. In vitro culture of melanocytes from segmental vitiligo-like nevus depigmentosus lesions and its clinical significance [J]. Chinese Journal of Dermatology, 2022, 55(9): 798-802. |
| [2] | Liu Yihe, Chen Zhiming, Feng Suying, Yang Yong. A case of ADULT syndrome without finger/toe deformities caused by a TP63 mutation [J]. Chinese Journal of Dermatology, 2022, 55(8): 709-712. |
| [3] | Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong. Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis [J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565. |
| [4] | Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu. Analysis of difficult-to-treat sites in patients with psoriasis who received biological therapy [J]. Chinese Journal of Dermatology, 2022, 55(7): 583-587. |
| [5] | Zhang Shimin, Hu Yunyun, Zhao Xiaoqing, Du Lianjun, Cao Hua, Zheng Jie. Application of imaging techniques in diagnosis and severity assessment of dermatomyositis [J]. Chinese Journal of Dermatology, 2022, 55(7): 637-640. |
| [6] | Lyu Sha, Wang Shuang, Wu Hanfei, Zhang Mingrui, Hu Xin, Li Fuqiu. Research progress in sporotrichosis [J]. Chinese Journal of Dermatology, 2022, 55(7): 629-632. |
| [7] | Committee on Autoimmune Diseases, China Dermatologist Association. Cyclosporine in the treatment of immune-related skin diseases: an expert proposal [J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479. |
| [8] | Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493. |
| [9] | Hu Yebei, Song Xiuzu. Tranexamic acid for the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(5): 460-462. |
| [10] | Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2021 [J]. Chinese Journal of Dermatology, 2022, 55(4): 369-372. |
| [11] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Calcium-based antimicrobial peptide compounds cooling gel for the treatment of atopic dermatitis: a randomized, double-blind controlled clinical study [J]. Chinese Journal of Dermatology, 2022, 55(4): 345-348. |
| [12] | Liu Bo, Song Xiaoting, Liao Shuanglu, Yu Miao, Luan Tingting, Li Ruoyu, Zhao Zuotao. Efficacy and safety of baricitinib in the treatment of moderate-to-severe atopic dermatitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 55(4): 304-307. |
| [13] | Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology. Expert consensus on clinical application of wet-wrap therapy for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 289-294. |
| [14] | Centre for Urticaria Research, Chinese Society of Dermatology. Guidelines for education of patients with chronic urticaria (2022) [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220305-e20220305. |
| [15] | Wang Min, He Pingxiu, Cheng Lifang, Hong Kechun, Ai Yong. A case of meningothelial hamartoma of the scalp [J]. Chinese Journal of Dermatology, 2022, 0(3): 20210080-e20210080. |
|
